Entrada Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by TD Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $786k | 48k | 16.45 |
| 2024-06-30 | $1.0M | 71k | 14.25 |
| 2024-03-31 | $1.0M | 71k | 14.17 |
| 2023-12-31 | $1.8M | 119k | 15.09 |
| 2023-09-30 | $1.9M | 119k | 15.80 |
| 2023-06-30 | $903k | 60k | 15.14 |
| 2023-03-31 | $865k | 60k | 14.50 |
| 2022-12-31 | $806k | 60k | 13.52 |
| 2022-09-30 | $925k | 60k | 15.55 |
| 2022-06-30 | $702k | 58k | 12.17 |
| 2022-03-31 | $542k | 58k | 9.40 |
| 2021-12-31 | $987k | 58k | 17.11 |